Lepu Biopharma set to jump most in 7 months on FY profit forecast
11/03/2026 03:05
** Lepu Biopharma 2157.HK jumps 10.2% to HK$5.19; on track for biggest one-day pct rise since August 5, 2025 ** Stock hits highest since January 26; on course for fifth consecutive session of gains ** Pharmaceutical products and new drugs developer expects 2025 net profit to be at least 200 mln yuan (~$29 mln) vs net loss of 411 mln yuan in 2024 ** Says improvement due to strong pickup in revenue through domestic commercialization, licensing activities ** YTD, stock down 1.8% ($1 = 6.8694 Chinese yuan renminbi) (Reporting by Donny Kwok) ((donny.kwok@thomsonreuters.com))
Recent news on Lepu Biopharma
See all newsChina's Lepu Biopharma H1 revenue rises 12.1% on higher drug sales
Hong Kong-listed Keymed Biosciences' gastric cancer drug meets late-stage trial goals
Brief: Lepu Biopharma Reports Positive Top-Line Results From Global Phase III Trial Of CMG901 (AZD0901)
Lepu Biopharma set to jump most in 7 months on FY profit forecast
Brief: Lepu Biopharma Expects FY Net Profit Attributable